Detalles de la búsqueda
1.
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton)
; 29(3): 117-125, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950597
2.
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Nephrology (Carlton)
; 28(6): 345-355, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076661
3.
Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages.
Mol Hum Reprod
; 27(1)2021 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33543288
4.
Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: A multicenter study.
Hepatol Res
; 50(8): 955-965, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455496
5.
Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis.
Biochem Biophys Res Commun
; 497(1): 207-213, 2018 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29428719
6.
Investigation of piperazine benzamides as human ß3 adrenergic receptor agonists for the treatment of overactive bladder.
Bioorg Med Chem Lett
; 27(4): 1094-1098, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28089699
7.
Non-alcoholic steatohepatitis-associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge.
Hepatol Res
; 47(1): 103-115, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992446
8.
Pharmacological evaluation of pioglitazone and candesartan cilexetil in a novel mouse model of non-alcoholic steatohepatitis, modified choline-deficient, amino acid-defined diet fed low-density lipoprotein receptor knockout mice.
Hepatol Res
; 47(6): 584-592, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27421062
9.
The Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel-Trenaunay Syndrome to Guide Designing a Proof-of-Concept Clinical Trial for Novel Therapeutic Intervention.
Lymphat Res Biol
; 22(1): 27-36, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112724
10.
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of ART-001 with a novel oral pediatric formulation in healthy subjects.
Clin Transl Sci
; 16(10): 1898-1910, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606073
11.
Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents.
J Pharmacol Exp Ther
; 338(1): 220-7, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21459965
12.
Transurethral bladder catheterization of male rhesus macaques: a refinement of approach.
J Med Primatol
; 40(5): 342-50, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21950722
13.
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model.
Cell Mol Gastroenterol Hepatol
; 5(1): 83-98.e10, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29276754
14.
Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.
J Med Chem
; 59(7): 2989-3002, 2016 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26954848
15.
Discovery of Vibegron: A Potent and Selective ß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.
J Med Chem
; 59(2): 609-23, 2016 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26709102
16.
Differential effects of TAK-802, a selective acetylcholinesterase inhibitor, and carbamate acetylcholinesterase inhibitors on contraction of the detrusor smooth muscle of the guinea pig.
Life Sci
; 77(26): 3276-86, 2005 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15978636
17.
Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs.
Eur J Pharmacol
; 494(2-3): 225-32, 2004 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-15212979
18.
Effects of TAK-802, a novel acetylcholinesterase inhibitor, on distension-induced rhythmic bladder contractions in rats and guinea pigs.
Eur J Pharmacol
; 485(1-3): 299-305, 2004 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-14757154
19.
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective ß3 adrenergic receptor agonists for the treatment of overactive bladder.
J Med Chem
; 57(4): 1437-53, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24437735
20.
Endocannabinoid involvement in endometriosis.
Pain
; 151(3): 703-710, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20833475